PL445779A1 - The use of essential oil from the roots of Carlina vulgaris L. for the prevention of SARS-CoV-2 virus infections and the treatment of COVID-19 disease - Google Patents

The use of essential oil from the roots of Carlina vulgaris L. for the prevention of SARS-CoV-2 virus infections and the treatment of COVID-19 disease

Info

Publication number
PL445779A1
PL445779A1 PL445779A PL44577923A PL445779A1 PL 445779 A1 PL445779 A1 PL 445779A1 PL 445779 A PL445779 A PL 445779A PL 44577923 A PL44577923 A PL 44577923A PL 445779 A1 PL445779 A1 PL 445779A1
Authority
PL
Poland
Prior art keywords
carlina
covid
vulgaris
roots
treatment
Prior art date
Application number
PL445779A
Other languages
Polish (pl)
Inventor
Sylwia Wnorowska
Weronika Kozłowska
Maciej Strzemski
Artur Wnorowski
Jacek Kurzepa
Agnieszka Hanaka
Sylwia Zielińska
Original Assignee
Uniwersytet Medyczny W Lublinie
Uniwersytet Medyczny Im. Piastów Śląskich We Wrocławiu
Uniwersytet Marii Curie-Skłodowskiej w Lublinie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Medyczny W Lublinie, Uniwersytet Medyczny Im. Piastów Śląskich We Wrocławiu, Uniwersytet Marii Curie-Skłodowskiej w Lublinie filed Critical Uniwersytet Medyczny W Lublinie
Priority to PL445779A priority Critical patent/PL445779A1/en
Publication of PL445779A1 publication Critical patent/PL445779A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Istotą wynalazku jest zastosowanie olejku eterycznego z korzeni Carlina vulgaris do profilaktyki zakażeń wirusem SARS CoV-2 oraz leczenia choroby COVID-19. Ponadto istotą wynalazku jest zastosowanie olejku eterycznego z korzeni Carlina vulgaris jako dodatku do suplementów diety stosowanych we wspomaganiu leczenia COVID.The essence of the invention is the use of essential oil from the roots of Carlina vulgaris for the prevention of SARS CoV-2 virus infections and the treatment of COVID-19 disease. In addition, the essence of the invention is the use of essential oil from the roots of Carlina vulgaris as an additive to dietary supplements used to support the treatment of COVID.

PL445779A 2023-08-07 2023-08-07 The use of essential oil from the roots of Carlina vulgaris L. for the prevention of SARS-CoV-2 virus infections and the treatment of COVID-19 disease PL445779A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL445779A PL445779A1 (en) 2023-08-07 2023-08-07 The use of essential oil from the roots of Carlina vulgaris L. for the prevention of SARS-CoV-2 virus infections and the treatment of COVID-19 disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL445779A PL445779A1 (en) 2023-08-07 2023-08-07 The use of essential oil from the roots of Carlina vulgaris L. for the prevention of SARS-CoV-2 virus infections and the treatment of COVID-19 disease

Publications (1)

Publication Number Publication Date
PL445779A1 true PL445779A1 (en) 2025-02-10

Family

ID=94479902

Family Applications (1)

Application Number Title Priority Date Filing Date
PL445779A PL445779A1 (en) 2023-08-07 2023-08-07 The use of essential oil from the roots of Carlina vulgaris L. for the prevention of SARS-CoV-2 virus infections and the treatment of COVID-19 disease

Country Status (1)

Country Link
PL (1) PL445779A1 (en)

Similar Documents

Publication Publication Date Title
GEAP202416095A (en) Substituted aminothiazoles as dgkzeta inhibitors for immune activation
CO2022018811A2 (en) Kras g12c protein inhibitors and their uses
MX2022000711A (en) PARP1 INHIBITORS.
PH12022550438A1 (en) N4-hydroxycytidine and derivatives and anti-viral uses related thereto
EA202092899A1 (en) HETEROARYL COMPOUNDS FOR THE TREATMENT OF GENTINGTON'S DISEASE
MA46990B1 (en) GLP-1 COMPOSITIONS AND ITS USES
EA201991951A1 (en) LOW-VISCOUS HIGH-CONCENTRATED COMPOSITIONS BASED ON EVOLOCUMABA AND METHODS FOR PRODUCING THEM
CY1113989T1 (en) 2,3-INDOLOAMINE DIAGNOSIS REGULATORS AND METHODS OF USING THESE
MX379263B (en) USE OF GLUTAMINASE INHIBITORS FOR THE TREATMENT OR PREVENTION OF CANCER.
BR112022003046A2 (en) Il-15 conjugates and uses thereof
MX2022003758A (en) ORAL CARE COMPOSITIONS COMPRISING BETA HOPS ACID AND AMINO ACID.
PH12020551994A1 (en) Tlr7 agonists
JOP20250051A1 (en) Alpha-1 antitrypsin modifiers
WO2020260956A3 (en) Self-emulsifying cannabidiol formulations
AU2017261919A1 (en) Fat and medical uses thereof
PL445779A1 (en) The use of essential oil from the roots of Carlina vulgaris L. for the prevention of SARS-CoV-2 virus infections and the treatment of COVID-19 disease
EA202090719A1 (en) MODIFIED NUCLEOSIDE AMIDOPHOSPHITES
JOP20240233A1 (en) Mutant CD24 proteins and their uses in cancer prevention and treatment
MX2024014771A (en) COMBINATION THERAPY
EA202190766A1 (en) IMMUNOMODULATORS, THEIR COMPOSITIONS AND METHODS OF APPLICATION
PL440293A1 (en) Application of carlina oxide for prevention of SARS-CoV-2 virus infection and treatment of COVID-19 disease
WO2024245930A3 (en) Inhibitors of expression and/or function
PH12022551280A1 (en) Tlr7 agonists
PL431336A1 (en) Lipopeptides, pharmaceutical composition, cosmetic composition, and lipopeptides for use as medicine
EA202090728A1 (en) APPLICATION OF NOR-URSODEOXYCHOLIC ACID TO REDUCE LIVER FAT